연구
교육
로그인
KR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
Department of Medical Oncology
Alessandro Passardi has not added Biography.
If you are Alessandro Passardi and would like to personalize this page please email our Author Liaison for assistance.
Impact of Pre-Treatment Lactate Dehydrogenase Levels on Prognosis and Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer.
PloS one , 2015 | Pubmed ID: 26244985
Prognostic role of serum concentrations of high-sensitivity C-reactive protein in patients with metastatic colorectal cancer: results from the ITACa trial.
Oncotarget Mar, 2016 | Pubmed ID: 26848624
Relationship between hypoxia and response to antiangiogenic therapy in metastatic colorectal cancer.
Oncotarget Jul, 2016 | Pubmed ID: 27081084
Immune Checkpoints as a Target for Colorectal Cancer Treatment.
International journal of molecular sciences Jun, 2017 | Pubmed ID: 28635639
Circulating Plasma Levels of miR-20b, miR-29b and miR-155 as Predictors of Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer.
International journal of molecular sciences Jan, 2018 | Pubmed ID: 29361687
Heterogeneity in Colorectal Cancer: A Challenge for Personalized Medicine?
International journal of molecular sciences Nov, 2018 | Pubmed ID: 30477151
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS
Matteo Canale1,
Giorgia Marisi1,
Alessandro Passardi2,
Emanuela Scarpi3,
Paola Ulivi1
1Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS,
2Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS,
3Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS
개인 정보 보호
이용 약관
정책
연락처
사서에게 추천하기
JoVE 뉴스레터
JoVE Journal
연구 방법 컬렉션
JoVE Encyclopedia of Experiments
아카이브
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
교수 리소스 센터
저자
사서
액세스
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유